Skip to content

Postinduction hypotension with ciprofol or propofol combined with alfentanil in geriatric patients-a single-centre, double-blind, randomised controlled trial

Postinduction hypotension with ciprofol or propofol combined with alfentanil in geriatric patients-a single-centre, double-blind, randomised controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110860
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-induction hypotension

Interventions

Test group:During induction, the patient received ciprofol (0.3mg/kg) until loss of consciousness.
Control group:During induction, the patient was administered propofol (1.5mg/kg) until loss of consciousness.

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
75 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. To undergo elective non-cardiac surgery; 2. Gender not limited, age >= 75 years old; 3. Require tracheal intubation for general anesthesia induction; 4. ASA I-III grade; 5. Voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. BMI >= 30 kg·m² ; 2. History of brain or thoracic, abdominal aortic aneurysm ; 3. Allergic to any drugs administered in the study ; 4. History of severe liver dysfunction, i.e., Child-Pugh C grade ; 5. Chronic kidney disease requiring dialysis treatment ; 6. Congestive heart failure, namely New York Heart Association classification III or IV ; 7. Untreated or unstable ischemic heart disease ; 8. History of severe aortic or mitral valve disease ; 9. History of multiple premature ventricular contractions, multiple premature atrial contractions, and atrial fibrillation ; 10. Use of antidepressants or antipsychotic drugs ; 11. Systolic blood pressure >= 200 mm Hg and/or diastolic blood pressure >= 120 mm Hg.

Design outcomes

Primary

MeasureTime frame
The incidence of hypotension after induction (GAIH);

Secondary

MeasureTime frame
The maximum value of MAP after tracheal intubation;The incidence of a MAP decrease of more than 20%;The incidence of a MAP decrease of more than 30%;The minimum heart rate after loss of consciousness induced by anesthesia;The time from the start of anesthesia to the loss of consciousness and the disappearance of eyelid reflexes;The total amount of anesthesia-inducing drugs (propofol, cyclopofol, alfentanil);The administration frequency and total dosage of vasoactive drugs;The incidence of atropine injection;The incidence of injection pain was evaluated using the four-point scale (0, no pain;) 1. Mild pain; 2. Moderate pain; 3. Severe pain;Choking cough during the induction period and postoperative nausea and vomiting;

Countries

china

Contacts

Public ContactHan Xiaodan

Zhongshan Hospital, Fudan University

han.xiaodan@zs-hospital.sh.cn+86 137 6122 3509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026